PRO-BANTHINE

This brand name is authorized in Australia, Japan, New Zealand, United Kingdom

Active ingredients

The drug PRO-BANTHINE contains one active pharmaceutical ingredient (API):

1 Propantheline UNII UX9Z118X9F - PROPANTHELINE BROMIDE

Propantheline inhibits parasympathetic activity by blocking the action of the neurohormone, acetylcholine, on the neuroeffector cell. This blocking action of propantheline is instrumental in reducing gastric acid secretion and gastrointestinal motor activity. Read about Propantheline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRO-BANTHINE Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A03AB05	Propantheline	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AB Synthetic anticholinergics, quaternary ammonium compounds
Discover more medicines within A03AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1953T
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 23533
Country: JP	医薬品医療機器総合機構	Identifier(s): 1231008F1032
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1753